ROGER JEFFS
CIK 1231615 · Chief Executive Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$193.34M
Companies
6
Total Filings
355
Lifetime Open-Market Net
-$191.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXSM | Director | 105,565 | $255.17 | $26.94M | -$15.63M | 31 | 2026-06-11 |
| LQDA | Chief Executive Officer | 2,179,175 | $71.23 | $155.22M | -$29.92M | 38 | 2026-05-28 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | — | $44.15 | — | $0 | 6 | 2021-06-28 |
| Dova Pharmaceuticals Inc. (DOVA) Delisted | Director | 0 | — | — | $701.9K | 7 | 2019-11-12 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 9,908 | $0.18 | $1.8K | $100.5K | 3 | 2018-09-07 |
| UTHR | President & Co-CEO | 20,486 | $545.96 | $11.18M | -$146.64M | 268 | 2016-03-15 |
Recent Filings · Page 5 of 36
355 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-04 | LQDA | Exer (M) | +47,423 | $0 | EDGAR |
| 2022-09-07 | LQDA | Buy (P) | +43,820 | $244.0K | EDGAR |
| 2022-09-01 | LQDA | Buy (P) | +993 | $4.9K | EDGAR |
| 2022-06-22 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2022-06-07 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2022-05-25 | LQDA | Buy (P) | +28,000 | $98.8K | EDGAR |
| 2022-04-20 | LQDA | Grant (A) | +154,167 | $0 | EDGAR |
| 2022-03-08 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2022-01-04 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2021-11-23 | AXSM | Buy (P) | +3,950 | $147.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.